According to a recent LinkedIn post from Latent, Ochsner Health’s Chief Pharmacy Officer Debbie Simonson is being highlighted ahead of her appearance at Becker’s Healthcare CPO Summit. The post emphasizes her focus on simplifying medication access workflows at Ochsner rather than adding operational complexity.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post cites Ochsner’s reported results from working with Latent, including a 127% increase in prior authorization throughput, a 67% reduction in review time, and an 89% cut in appeal review time. For investors, these metrics suggest that Latent’s technology may deliver measurable efficiency gains for large health systems, potentially strengthening its value proposition in the healthcare IT and pharmacy workflow market.
The association with a major provider such as Ochsner could indicate growing traction among enterprise-scale customers, which may support Latent’s pricing power and sales pipeline over time. Participation in an industry forum like Becker’s CPO Summit also positions the company alongside senior decision makers, which could translate into additional partnerships or expansions if the reported performance gains are replicable across other health systems.